Can a simple test predict breast cancer brain spread?
NCT ID NCT07447544
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines stored tumor tissue and blood samples from 22 women with early breast cancer to find genetic or chemical markers that might predict whether the cancer will spread to the brain. Researchers will compare women whose cancer did spread to the brain with those whose did not. The goal is to identify warning signs that could lead to earlier detection, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a blood or tissue test that identifies breast cancer patients at higher risk for brain metastases, allowing closer monitoring.
- What could go wrong
- This is a very small, observational study (22 people) that only looks for patterns. It does not test any treatment, so any potential test would need much larger studies to confirm.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?